The most recent review of the effectiveness of myopia management...

The most recent review of the effectiveness of myopia management strategies can be found in this paper:



The key table of studies shows the leading position of Naturalvue (based on current data) in terms of slowing myopia:



Finally, some nice commentary on the potential of Naturalvue included:


The impact of similar results for Naturalvue in the 1-year results from the RCT at the end of the year would be substantial. IMHO, Thorney won't be considering any corporate action until the full value of Naturalvue is on display with the likelihood of FDA approval based on the 1-year RCT results.